Affiliation: Johns Hopkins University
- Cost-benefit analysis of total, free/total, and complexed prostate-specific antigen for prostate cancer screeningLars Ellison
Brady Urological Institute, The Johns Hopkins Medical Institution, Baltimore, Maryland 21287, USA
Urology 60:42-6. 2002..8 ng/mL. The use of cPSA with a threshold of 3.0 ng/mL identifies a similar number of cancers with fewer biopsies than tPSA at 4.0 ng/mL...